At the Competitiveness Council on Monday 25 September, Austria and Germany insisted on the need to ensure that the EU pharmaceutical package presented by the European Commission “does not establish measures that hamper innovation and investment and create legal uncertainty that weakens us strategically as a location, particularly in these difficult times for competitiveness”, according to Austrian minister Martin Georg Kocher.
Under other business, Austria and Germany asked to speak...